Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part II: nasopharyngeal carcinoma. Read more about Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part II: nasopharyngeal carcinoma.
Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part I: carcinoma of non-nasopharyngeal sites. Read more about Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part I: carcinoma of non-nasopharyngeal sites.
Reducing radiation-related morbidity in the treatment of nasopharyngeal carcinoma. Read more about Reducing radiation-related morbidity in the treatment of nasopharyngeal carcinoma.
Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers. Read more about Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers.
Targeted PET imaging for prostate-specific membrane antigen in prostate cancer. Read more about Targeted PET imaging for prostate-specific membrane antigen in prostate cancer.
Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas. Read more about Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas.
Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers. Read more about Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers.
MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer. Read more about MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer.
Integrated health systems and evidence-based care: standardizing treatment to eliminate cancer disparities. Read more about Integrated health systems and evidence-based care: standardizing treatment to eliminate cancer disparities.
To screen or not to screen older women for breast cancer: a conundrum. Read more about To screen or not to screen older women for breast cancer: a conundrum.
